Does Blue Cross Blue Shield of Texas Cover Wegovy?
The verdict
Conditional on most plans
Blue Cross Blue Shield of Texas, an HCSC-operated plan, covers Wegovy for weight loss on commercial/employer plans only where the employer purchased the anti-obesity benefit; ACA/individual plans generally exclude it, Texas Medicaid excludes GLP-1s for obesity entirely, and drug-level formulary detail is not publicly published. Verify coverage via the BCBS Texas drug-lookup tool.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Blue Cross Blue Shield of Texas using your member ID.
Key facts
Texas Medicaid does not cover GLP-1s for obesity — a hard stop for Medicaid members seeking Wegovy for weight management.
KFF — Medicaid Coverage of and Spending on GLP-1s (January 2026)
BCBS of Texas and BCBS of Illinois are both HCSC plans sharing formulary architecture — the Wegovy coverage logic is the same shape across both states.
HCSC (Health Care Service Corporation) public plan information
Wegovy list price: $1,349/month in 2026; Novo Nordisk announced a cut to approximately $675/month effective January 1, 2027.
Novo Nordisk press release, 2026
Medicare vs. commercial coverage
Whether Blue Cross Blue Shield of Texas covers Wegovy depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D cannot cover Wegovy for weight loss by statute — this applies to all BCBS of Texas Medicare Advantage and Part D plans. BCBS Texas Medicare plans can cover Wegovy for the cardiovascular risk-reduction indication (adults with established CVD who are overweight or obese) with prior authorization. The Medicare GLP-1 Bridge launches July 1, 2026, providing eligible beneficiaries weight-loss access to Wegovy at $50/month through December 31, 2027 — operating outside Part D, so the $50 does not count toward the $2,100 OOP cap or TrOOP. NovoCare savings card is not available to Medicare beneficiaries.
Commercial / Employer
Group & marketplace plans
BCBS of Texas is operated by HCSC, which also runs BCBS of Illinois. These HCSC plans share formulary architecture, meaning the Wegovy coverage logic is the same shape across both states: commercial weight-loss coverage is employer-dependent, ACA plans generally exclude it, and specific drug-level detail is not publicly published. Where an employer has purchased the anti-obesity benefit, prior authorization is required with standard BMI criteria (BMI 30 or higher, or BMI 27 or higher with a weight-related comorbidity) and documented lifestyle program participation. A 5% weight-loss renewal criterion is the industry standard for employer GLP-1 coverage; verify current HCSC/BCBS-TX PA criteria on the plan's drug-lookup tool. If the employer carved out anti-obesity drugs, that is a benefit exclusion — not a medical-necessity denial — and is not appealable through PA. ACA/individual-market plans in Texas generally exclude Wegovy for weight loss. Texas Medicaid does not cover GLP-1s for obesity as of 2026 — a state-specific hard stop for Medicaid members. Commercially insured members whose plan covers Wegovy may use the NovoCare savings card ($25/month, max $100 per 28-day supply). Not available to Medicare or Medicaid beneficiaries.
The 4 boxes you must tick to get approved
Commercial plans that will consider Wegovy require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 4 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Wegovy actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
$1,349/month (Novo Nordisk published list price, 28-day supply). NovoCare self-pay: approximately $349/month for standard injection doses after an introductory period.
List price with no coverage — before any manufacturer savings card.
With coverage
Plan-specific specialty-tier cost-share — not publicly published for BCBS Texas Wegovy. NovoCare savings card: commercially insured members with covered plans may pay as little as $25/month (up to $100 per 28-day supply).
Typical monthly copay once prior authorization is approved.
Bridge program
Medicare GLP-1 Bridge: $50/month for eligible Medicare beneficiaries from July 1, 2026 through December 31, 2027. Operates outside Part D — not applied to the $2,100 OOP cap.
Reduced copay through the assistance program, where eligible.
All cost figures are estimates and vary by plan tier, deductible phase, and pharmacy. BCBS of Texas does not publish specific Wegovy cost-share — verify on your plan before starting treatment.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Ask HR whether anti-obesity medications are covered
Before any formulary search or PA effort, confirm with your employer's HR or benefits team that weight-loss drugs are included in your BCBS Texas plan. If they are carved out, a PA will not succeed — that is a benefit exclusion decision. Texas Medicaid members should also verify current GLP-1 obesity coverage status with their plan administrator.
- 2
Use the BCBS of Texas drug-lookup tool
Visit bcbstx.com and use the drug search or formulary tool with your member ID. Search for 'Wegovy' or 'semaglutide 2.4 mg' to confirm whether your specific plan covers it, the tier placement, and PA requirements. Results vary by plan — a single BCBS Texas member ID does not guarantee a single answer.
- 3
Work with your prescriber to submit prior authorization
If your plan covers Wegovy, ask your doctor to submit a PA with BMI documentation, weight-related comorbidities (if applicable), and lifestyle program evidence. Track your progress throughout treatment — renewal will require documented weight loss.
Options if Blue Cross Blue Shield of Texas won't cover Wegovy
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
BCBS Texas Mounjaro coverage (T2D only)
If you have type 2 diabetes, BCBS of Texas covers Mounjaro (tirzepatide) for that indication with prior authorization. Mounjaro is not FDA-approved for weight loss — it is T2D on-label. Do not confuse Mounjaro with Zepbound, which is the FDA-approved weight-loss formulation of tirzepatide.
NovoCare self-pay program
NovoCare Pharmacy offers Wegovy at approximately $349/month without insurance. Introductory rate approximately $199/month for the 0.25 and 0.5 mg doses through December 31, 2026. Novo Nordisk has announced list price reductions to approximately $675/month effective January 1, 2027.
Compounded semaglutide
Compounded semaglutide is available without insurance at a lower cost. See the Curex offer below. Compounded medications are not the same as Wegovy and have not been approved by the FDA.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
BCBS of Texas covers Wegovy for weight loss on commercial plans only where the employer purchased anti-obesity drug coverage. The formulary is not publicly published, so coverage cannot be confirmed without checking your specific plan. ACA/individual plans generally exclude it. Texas Medicaid does not cover GLP-1s for obesity. Use the BCBS Texas drug-lookup tool and ask HR before building a treatment plan around covered Wegovy.
Both BCBS of Texas and BCBS of Illinois are operated by HCSC and share formulary architecture, so the Wegovy coverage logic is parallel: commercial coverage is employer-dependent, ACA plans generally exclude it, and drug-level detail is not publicly published. The key difference is state-specific: Texas Medicaid excludes GLP-1s for obesity entirely, while Illinois Medicaid coverage is state-dependent. Verify your specific plan on the respective drug-lookup tool.
No. Texas Medicaid does not cover GLP-1s for obesity as of 2026. Wegovy is not a diabetes drug, so it cannot be routed through a T2D benefit. The non-weight-loss FDA indications for Wegovy — cardiovascular risk reduction and MASH — may be covered through Medicaid for qualifying members; verify current Texas Medicaid preferred drug list status with your plan administrator.
A PA denial based on medical necessity is appealable with additional clinical documentation. A benefit exclusion — the employer carved out anti-obesity drugs — is generally not appealable through the standard PA process, because the drug category is simply not in the plan. Ask BCBS Texas in writing whether your denial is a medical-necessity determination or a benefit exclusion before deciding whether to pursue an appeal.
The Novo Nordisk published list price for Wegovy is $1,349/month for a 28-day supply. NovoCare self-pay pricing is approximately $349/month for standard doses (introductory pricing applies for the first two dose levels through December 31, 2026). Novo Nordisk has announced a list-price reduction to approximately $675/month effective January 1, 2027. Compounded semaglutide from $49/month is also available through platforms like Curex — it is not the same medication as Wegovy.
Related Articles
Does BCBS North Carolina Cover Wegovy? 2026 | Curex
BCBS North Carolina: NC State Health Plan dropped weight-loss GLP-1s in 2024; NC Medicaid removed obesity coverage October 2025. Verify your specific plan.
Read moreDoes BCBS of Arizona Cover Wegovy? 2026 Guide | Curex
BCBS of Arizona covers Wegovy only where your employer opted in; formulary not published. Verify via drug-lookup and confirm with HR first.
Read moreDoes Blue Cross Blue Shield of Illinois Cover Wegovy? | Curex
BCBS Illinois (HCSC) covers Wegovy only where your employer opts in. ACA plans exclude it. Formulary not public — verify on your plan's drug-lookup tool.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes BCBS Michigan Cover Wegovy? 2026 Coverage Guide | Curex
BCBS Michigan ended weight-loss GLP-1 coverage on fully insured plans in 2025. Self-funded groups may opt in. Michigan Medicaid covers Wegovy as preferred.
Read moreDoes Blue Cross MN Cover Wegovy? 2026 Employer Guide | Curex
Blue Cross MN covers Wegovy only where your employer bought the anti-obesity benefit. Not published at drug level — check plan drug lookup and ask HR.
Read moreWhether or not Blue Cross Blue Shield of Texas covers Wegovy, there's a path that skips insurance
BCBS of Texas covers Wegovy for weight loss only with an employer anti-obesity benefit, and Texas Medicaid excludes it for obesity. For patients without a covered route, Curex offers compounded semaglutide from $49/mo (compounded tirzepatide from $149/mo) — no insurance, no prior authorization. Compounded semaglutide is not the same medication as Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Wegovy and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Blue Cross Blue Shield of Texas before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Wegovy and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.